Obesity management approaches
From Goodfellow Unit by The Goodfellow Unit (University of Auckland)
March 10, 2026 · 35 min · Episode 280
About this episode
Ole Schmiedel discusses the new weight loss drug Mounjaro, its mechanism of action, and its implications for obesity management.
In this episode Ole Schmiedel discusses Mounjaro, a new weight loss drug, with a focus on its mechanism of action, practical use, side effects, nutritional considerations, and long-term safety. The conversation provides insights into how Mounjaro differs from previous GLP-1 receptor agonists, expected weight loss outcomes, and the importance of monitoring patients while on the medication.
People in this episode
Guest: Ole Schmiedel
Topics covered
- obesity management
- weight loss drugs
- Mounjaro
- GLP-1 receptor agonists
- side effects
- nutritional considerations
- long-term safety
Keywords
- obesity
- weight loss
- Mounjaro
- GLP-1
- side effects
- nutrition
- safety
Mentioned in this episode
Products: Mounjaro, GLP-1 receptor agonists
More episodes of Goodfellow Unit
- Mastering Health Literacy · June 3, 2026 · 34 min
- Type 2 Diabetes Management · May 20, 2026 · 31 min
- Familial Hyperlipidemia · May 5, 2026 · 38 min
- A.I. Medical Co-Pilots · April 22, 2026 · 27 min
- Refugee Health · April 7, 2026 · 24 min
- Sepsis · March 24, 2026 · 32 min
Explore listener stats, chart rankings, contacts and more on the Goodfellow Unit podcast page.